May 20, 2010 – A fractional flow reserve (FFR) guide wire gained U.S. Food and Drug Administration (FDA) clearance and European CE mark to speed treatment of multivessel disease. These blockages usually have more tortuous tissue to navigate through and it takes longer to guide several devices over-the-wire to deliver treatment. The PrimeWire Prestige Pressure Guide Wire is designed to reduce the number of catheters needed, combining FFR with a guide wire. The pressure guide wire is compatible with Volcano's integrated, multimodality consoles, stand-alone physiology systems and various hemodynamic monitoring systems. Commercial launch of the PrimeWire Prestige is expected in June 2010. The PrimeWire Prestige Pressure Guide Wire has a redesigned core intended to improve mechanical performance, such as torque transmission, vessel navigation, and support. A recent internal study showed Prestige outperformed Volcano’s previous generation PrimeWire with respect to torque transmission. The redesigned tip also improves tactile feel and tip shape memory. The new wire will launch simultaneously with the new upgraded v3.2 software for the Volcano s5i system, which provides a better FFR workflow for ease of use. "The PrimeWire Prestige represents a significant improvement in performance to the previous generation FFR wire," said Hoang Thai, M.D., director, cardiac catheterization laboratory and interventional cardiology, Southern Arizona Veterans' Affairs Health Care System Medical Center. He is also associate director, interventional cardiology fellowship program at Sarver Heart Center, University of Arizona. "I have been committed to using FFR in these complex patients for some time, and it is great to see a product evolving along with my practice to make my decision-making in the cath lab easier and more predictable." For more information: www.volcanocorp.com
April 03, 2024 
